Glypicans display different activities in tumor development, while glypican-1 overexpression in tumor cells triggers mitogenic response [4], absence of glypican-3 expression in breast cancer cell lines inhibits mammary tumorigenesis [19]. The gene discussed is GPC3; the disease is breast carcinoma.